Document is current
Any future updates will be listed below
-
Authors
Zhang, Chen https://orcid.org/0000-0002-0785-1292
Li, Haotian
Poluektova, Larisa Y. https://orcid.org/0000-0001-7339-8732
Gendelman, Howard E. https://orcid.org/0000-0002-7831-0370
Dash, Prasanta K. https://orcid.org/0000-0002-8250-2359
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH115860, R01MH121402)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (R24OD018546)
Developmental grant provided by the University of Nebraska Medical Center to Prasanta K Dash.
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 9 July 2025
First Online: 19 July 2025
Competing interests
: HEG co-founded Exavir Therapeutics, Inc., a company formed to develop LA ART. All other listed authors have no competing interests.
